Buster et al. also revealed that PEG-IFN-α-2b induced higher rate of HBeAg seroconversion, HBV DNA inhibition, and improvement of liver fibrosis in HBeAg-positive CHB patients with advanced fibrosis (26). The gene discussed is IFNA1; the disease is Hepatic fibrosis.